Amélia Sarmento

476 total citations
17 papers, 390 citations indexed

About

Amélia Sarmento is a scholar working on Epidemiology, Pharmacology and Immunology. According to data from OpenAlex, Amélia Sarmento has authored 17 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Pharmacology and 5 papers in Immunology. Recurrent topics in Amélia Sarmento's work include Mycobacterium research and diagnosis (9 papers), Pharmacological Effects of Natural Compounds (5 papers) and Tuberculosis Research and Epidemiology (3 papers). Amélia Sarmento is often cited by papers focused on Mycobacterium research and diagnosis (9 papers), Pharmacological Effects of Natural Compounds (5 papers) and Tuberculosis Research and Epidemiology (3 papers). Amélia Sarmento collaborates with scholars based in Portugal, United Kingdom and Brazil. Amélia Sarmento's co-authors include Rui Appelberg, António Afonso, Naïr Nazareth, Guilherme Macedo, Fernando Magro, António G. Castro, Lúcia Guilhermino, Fernanda Marques, Anthony E. Ellis and Susana Lopes and has published in prestigious journals such as Infection and Immunity, Inflammatory Bowel Diseases and Fish & Shellfish Immunology.

In The Last Decade

Amélia Sarmento

15 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amélia Sarmento Portugal 10 180 151 121 88 67 17 390
Siddhartha Das United States 12 169 0.9× 65 0.4× 48 0.4× 259 2.9× 36 0.5× 25 584
Magnus Steigedal Norway 11 198 1.1× 51 0.3× 165 1.4× 156 1.8× 50 0.7× 14 409
David Pajuelo Spain 11 80 0.4× 205 1.4× 101 0.8× 160 1.8× 67 1.0× 12 454
Kirsten L. Hokeness United States 9 131 0.7× 238 1.6× 62 0.5× 54 0.6× 21 0.3× 12 425
R. Sugimoto Japan 9 195 1.1× 114 0.8× 36 0.3× 116 1.3× 10 0.1× 13 540
Katharina L. Becker Netherlands 8 198 1.1× 159 1.1× 264 2.2× 96 1.1× 12 0.2× 10 467
Krishnaveni Mohareer India 11 170 0.9× 95 0.6× 204 1.7× 150 1.7× 16 0.2× 19 362
Garry Lund Canada 12 232 1.3× 66 0.4× 75 0.6× 122 1.4× 27 0.4× 21 501
Nadine Vincent France 10 52 0.3× 54 0.4× 39 0.3× 183 2.1× 48 0.7× 24 443
Cherelyn Vella United Kingdom 11 78 0.4× 90 0.6× 98 0.8× 65 0.7× 33 0.5× 23 376

Countries citing papers authored by Amélia Sarmento

Since Specialization
Citations

This map shows the geographic impact of Amélia Sarmento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélia Sarmento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélia Sarmento more than expected).

Fields of papers citing papers by Amélia Sarmento

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélia Sarmento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélia Sarmento. The network helps show where Amélia Sarmento may publish in the future.

Co-authorship network of co-authors of Amélia Sarmento

This figure shows the co-authorship network connecting the top 25 collaborators of Amélia Sarmento. A scholar is included among the top collaborators of Amélia Sarmento based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélia Sarmento. Amélia Sarmento is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
3.
Estevinho, María Manuela, José Manuel Cabeda, Elisabete Machado, et al.. (2023). Viable Mycobacterium avium subsp. paratuberculosis Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients. Microorganisms. 11(6). 1520–1520. 7 indexed citations
4.
Duro, Mary, et al.. (2022). Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection. Irish Journal of Medical Science (1971 -). 192(2). 731–739. 2 indexed citations
5.
Costa, Marta, Pedro Sarmento, Maria Conceição Manso, et al.. (2021). DNA-based detection of <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> in domestic and municipal water from Porto (Portugal), an area of high IBD prevalence. AIMS Microbiology. 7(2). 163–174. 6 indexed citations
6.
Cerqueira, Fátima, Naïr Nazareth, Rui Medeiros, et al.. (2019). 1,2-Dihydroxyxanthone: Effect on A375-C5 Melanoma Cell Growth Associated with Interference with THP-1 Human Macrophage Activity. Pharmaceuticals. 12(2). 85–85. 8 indexed citations
7.
Nazareth, Naïr, Fernando Magro, Elisabete Machado, et al.. (2015). Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease. Medical Microbiology and Immunology. 204(6). 681–692. 34 indexed citations
8.
Nazareth, Naïr, Fernando Magro, Rui Appelberg, et al.. (2015). Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatment. Medical Microbiology and Immunology. 204(6). 647–656. 8 indexed citations
9.
Nazareth, Naïr, Fernando Magro, Jani Silva, et al.. (2014). Infliximab therapy increases the frequency of circulating CD16+ monocytes and modifies macrophage cytokine response to bacterial infection. Clinical & Experimental Immunology. 177(3). 703–711. 25 indexed citations
10.
Magro, Fernando, João Santos‐Antunes, Andreia Albuquerque, et al.. (2013). Epstein–Barr Virus in Inflammatory Bowel Disease—Correlation with Different Therapeutic Regimens. Inflammatory Bowel Diseases. 19(8). 1710–1716. 35 indexed citations
11.
Nazareth, Naïr, Fernando Magro, Ana Rita Castro, et al.. (2011). Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection. Immunobiology. 216(8). 961–970. 34 indexed citations
12.
Sarmento, Amélia, Lúcia Guilhermino, & António Afonso. (2004). Mercury chloride effects on the function and cellular integrity of sea bass (Dicentrarchus labrax) head kidney macrophages. Fish & Shellfish Immunology. 17(5). 489–498. 30 indexed citations
13.
Sarmento, Amélia, Fernanda Marques, Anthony E. Ellis, & António Afonso. (2003). Modulation of the activity of sea bass (Dicentrarchus labrax) head-kidney macrophages by macrophage activating factor(s) and lipopolysaccharide. Fish & Shellfish Immunology. 16(2). 79–92. 29 indexed citations
14.
Sarmento, Amélia & Rui Appelberg. (1996). Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium. Infection and Immunity. 64(8). 3224–3230. 36 indexed citations
16.
Appelberg, Rui, Amélia Sarmento, & António G. Castro. (1995). Tumour necrosis factor-alpha (TNF-α) in the host resistance to mycobacteria of distinct virulence. Clinical & Experimental Immunology. 101(2). 308–313. 33 indexed citations
17.
Appelberg, Rui & Amélia Sarmento. (1990). The role of macrophage activation and ofBcg-encoded macrophage function(s) in the control ofMycobacterium aviuminfection in mice. Clinical & Experimental Immunology. 80(3). 324–331. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026